Cyclospora Cases Pass 19,000 as CDC Tracks Eight Listeria and 21 Salmonella Investigations
The CDC has recorded 19,595 laboratory-confirmed cases of cyclosporiasis between 1 May and 8 September 2026, including 1,043 hospitalisations and two deaths.
The CDC has recorded 19,595 laboratory-confirmed cases of cyclosporiasis between 1 May and 8 September 2026, including 1,043 hospitalisations and two deaths.
An analysis of roughly 400,000 public forum posts written by people taking GLP-1 drugs has surfaced effects that feature little in the trial literature, including menstrual changes and…
A compound called AP503 built bone and slowed bone loss in animals by activating GPR133, a cell-surface receptor that has drawn little attention in skeletal research until now.
A new Centers for Disease Control and Prevention (CDC) report finds childhood vaccine exemptions at a record high as measles cases rise across the country.
A small clinical trial suggests oral fecal microbiome transplantation (FMT), sometimes called “poop pills,” may raise peanut tolerance in some adults with peanut allergy, but the…
Federal health officials are warning that Candida auris, a drug-resistant yeast, is spreading in U.S. healthcare settings.
The FDA has approved SIMTRIYO, a new daily extended-release tablet containing centanafadine, as a treatment option for attention deficit hyperactivity disorder (ADHD) in adults and…
The Food and Drug Administration has approved an over-the-counter combination pill that pairs acetaminophen (Tylenol) with naproxen sodium (Aleve).
Hot weather can be more than uncomfortable — for people taking certain medicines, it can increase the risk of heat-related illness.
Summer heat can be more dangerous if you take certain medicines. Some drugs interfere with your body’s ability to cool itself, reduce thirst, or increase fluid loss — all of which…
Simone Kelly, a 24-year-old volunteer EMT and pre‑med student, became a viral symbol of quick action and compassion after using Narcan to revive an unresponsive man during the New York…
Emmy-winning actor Mayim Bialik has described a severe reaction after a single low dose of a GLP-1 medication, leaving her with weeks of debilitating gastrointestinal symptoms.